L&K Biomed 추진 ALIF Height-Expandable Cage... Strengthening Product Differentiation

[Asia Economy Reporter Hyungsoo Park] Spinal implant company L&K Biomed announced on the 12th that Professor John Park, a neurosurgeon at Stanford University School of Medicine in the United States, recently visited Korea to promote the excellence of the spinal surgery method called 'Anterior Lumbar Interbody Fusion (ALIF)'.

Anterior Lumbar Interbody Fusion is a surgery in which a cage is inserted through the front, abdominal side of the patient. Among the cages inserted during spinal surgery, it is the largest in size and supports the greatest portion of the spinal bone. It has a low risk of subsidence.

This surgical method does not cut the patient's spinal bone and accurately restores the original angle of the spinal bone. It reduces risks such as excessive bleeding and infection, and preserves the patient's spinal tissues including muscles and nerves well. It helps patients return to daily life quickly after surgery and is relatively less costly.

Professor John Park completed a fellowship at UCLA in the United States and is a Korean-American spine specialist. He is the first to serve as a chair professor in neurosurgery in the history of Stanford University School of Medicine. He recently participated as an author of a neurosurgery textbook. He is recognized as the most authoritative spine specialist in the field of spinal surgery not only in the United States but worldwide.

Professor Park said, "Recently, height-expandable cage technology has newly established itself as a global trend," and introduced, "Currently, there are two height-expandable ALIF cages approved by the FDA in the medical device market." He added, "It seems that they have not been officially launched yet," and "Since height-expandable cages require advanced technology, many difficulties are expected until the product is released."

He said, "I have heard the news that L&K Biomed is developing a height-expandable ALIF cage and have high expectations."

L&K Biomed is a global spinal medical specialist company established in 2008 for the development, manufacturing, and sales of spinal implants. It has received product approvals from the U.S. Food and Drug Administration (FDA), the European Union's Conformit? Europ?enne (CE), and the Korean Ministry of Food and Drug Safety (MFDS). It mainly designs, develops, manufactures, and sells spinal fixation devices and spinal surgery products used in orthopedics and neurosurgery.

Park Geun-joo, CEO of L&K Biomed, said, "With the recent trend of aging and the increase in the obese population, the number of spinal patients is increasing, and interest in the anterior lumbar interbody fusion method, which approaches from the front unlike the conventional posterior approach, is growing."

He continued, "We are developing a height-expandable ALIF cage necessary for this surgical method with accumulated technology," and explained, "Once approved by the U.S. FDA and officially introduced to the domestic and international medical device markets, it will be a competitive and differentiated core product compared to competitors."

This content was produced with the assistance of AI translation services.